Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02294175 · ClinicalTrials.gov registry record · NA
Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm
A NA study of Bacterial Infection and Lower Extremity or Diabetic Foot Ulcers, sponsored by North Florida Foundation for Research and Education.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT02294175 is a NA study of Bacterial Infection and Lower Extremity or Diabetic Foot Ulcers that has completed, run by North Florida Foundation for Research and Education. The registered enrollment target is 45 participants, below the 100-participant average among 8 other Bacterial Infection trials with a reported enrollment target (55% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02294175, a NA study of Bacterial Infection and Lower Extremity or Diabetic Foot Ulcers, has completed, sponsored by North Florida Foundation for Research and Education.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective study of Veterans with chronic lower extremity or diabetic foot ulcers who will be randomized to either a Larval Debridement Therapy group (Biobags every 4 days x 2 applications) or a Sharp Debridement Therapy group (standard or control weekly x 2) during an 8 day study period.
Conditions Studied
Interventions
- DEVICE Larval Debridement Therapy
- PROCEDURE Bedside Sharp Debridement
Study Locations (2)
Florida
- North Florida Regional Medical Center - Gainesville
- North Florida / South Georgia Veterans Health System - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02294175
The ClinicalTrials.gov registry entry for NCT02294175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 8 other Bacterial Infection trials with a reported enrollment target (55% lower). The listed sponsor is North Florida Foundation for Research and Education, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bacterial Infection appearing as the primary indexed condition, and to 2 interventions - of which Larval Debridement Therapy is the first listed.
NCT02294175 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02294175 about?
NCT02294175 is a clinical study titled "Larval Debridement Therapy Versus Sharp Debridement to Remove Biofilm". This is a prospective study of Veterans with chronic lower extremity or diabetic foot ulcers who will be randomized to either a Larval Debridement Therapy group (Biobags every 4 days x 2 applications) or a Sharp Debridement Therapy group (standard or control weekly x 2) during an 8 day study period.
What is the current status of trial NCT02294175?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-01. Estimated completion is 2018-03-24.
What conditions does trial NCT02294175 study?
This clinical trial studies the following conditions: Bacterial Infection, Lower Extremity or Diabetic Foot Ulcers.
What interventions are being tested in trial NCT02294175?
The interventions under investigation include: Larval Debridement Therapy (DEVICE), Bedside Sharp Debridement (PROCEDURE).
Who is sponsoring clinical trial NCT02294175?
This trial is sponsored by North Florida Foundation for Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02294175 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimization of Beta-lactam Dosing in Critically Ill Patients With Cystatin C (OPTIMIZE-GNI)
RECRUITING · Phase 4
-
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
RECRUITING · Phase 4
-
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
COMPLETED · Phase 2
-
Safety of Intravenous Apramycin in Adults
COMPLETED · Phase 1
-
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
COMPLETED · Phase 2
-
A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.